Mckesson: Gemcitabine Injection
Recall Summary McKesson is recalling Gemcitabine Injection (a cancer medication) distributed nationwide because the product was stored at room temperature instead of in a refrigerator, which may have affected its quality. The recall affects vials with NDC 0143-9341-01 that were distributed across all U.S. states and Washington, D.C. This medication is used for intravenous infusion in medical settings.
- Recalling firm
- McKesson
- Product
- Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01
- Reason
- Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-10
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/344eb8fb-7a51-48cb-be1c-91ecdcb46373